Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2022 Went through Y Combinator
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Discover fast, reliable, easy at home testing with MyUTI. Our proven PCR testing for UTIs, BV and STIs delivers accurate results, test from…
En CartaVenture round $6.2M · 2 mo ago • 11-50 employees
En Carta Diagnostics develops molecular tests, as easy to use as rapid tests, as precise as a PCR machine. We currently offer Lyme disease…
2NA FISHPre-Seed · 8 mo ago • Founded 2024 • 11-50 employees
Precision diagnostics through spatial transcriptomics. We combine nanotechnology and AI to measure RNA biomarkers at single-cell level…
SmartCatchFounded 2016
Smartcatch is lifting the current locks on CTC liquid biopsy by developing a range of compact, portable, easy-to-use products that can…
MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases. As a leader in…
Combining the power of liquid biopsy and AI-driven epigenetics, we deliver accurate cancer detection. Our approach transforms diagnostics…

Overview

Expanding PCR testing to a whole new range of conditions. Making precision diagnostics accessible around the planet. Our technology leverages widely accessible PCR instrumentation to perform simple diagnosis that would otherwise require complex, expensive machines.